Advertising Disclosure Email Disclosure
PDF version

David J. Krolikowski

Co-Chair, Medical Device & Pharmaceutical Liability Practice Group
620 Freedom Business Center
Suite 300
King of Prussia, PA 19406
(610) 354-8291
(610) 354-8299 - Fax

David’s practice focuses upon finding solutions to complex problems in high-exposure claims aided by his significant technical background in biotechnology and chemistry. This has involved him acting as national Specialty Counsel for a major insurance company, litigating Birth-Injury, Catastrophic Injury and Stroke Claims throughout the country. Read more about David's work with the Birth and Catastrophic Injury Litigation Practice Group here.

David also serves as the Co-Chair of the firm's Medical Device and Pharmaceutical Liability Practice Group, where his practice involves the representation of pharmaceutical/medical device companies in Federal Multi-District Litigation, and mass torts. He is also experienced litigating complicated environmental coverage actions, and handling complex, multi-party litigation and environmental contamination claims.

With more than 10 years of experience in research and development activities in chemistry and biology for major pharmaceutical companies, David now leverages this knowledge in defending his clients. In 1998, he graduated cum laude from Temple University where he earned a Bachelor of Science in Biology with an emphasis in Molecular Biology. While earning his degree, David worked as a Combinatorial Chemist for Rhone-Poulenc-Rorer Pharmaceuticals where he helped develop a novel activated resin for chemical library synthesis. (See Salvino, et al., under Published Works). He subsequently joined the gene therapy/cardiovascular department where he conducted extensive research into the molecular mechanism and possible treatments of cardio infarctions. (See Guo, et al. and Liu et al., under Published Works).

In 2000, David joined the immunology/oncology department of Sanofi-Aventis Pharmaceuticals where he managed a portfolio of potential drug candidates. It was during this time that David became admitted to the United States Patent and Trademark Bar and conducted strategic analysis related to potential new drug candidates. David then went to law school where in 2005, he graduated from Rutgers School of Law, in Newark, NJ. After graduation, David began to litigate product liability, medical malpractice and commercial matters, and was also involved in developing corporate compliance guidelines for a major health care corporation.

Classes/Seminars Taught

  • Updated Guidelines for Stroke Treatment and Potential Impact Upon Trial Strategy - AIG Complex Unit 2016

  • Litigation Survival Guide for Nurses, Doylestown Hospital Nurses' Week keynote speaker, May 9, 2014

  • Lessons Learned From Defending High-Exposure Birth-Injury Cases, AIG, March 12, 2014

  • Social Media in Litigation, AIG, March 12, 2014

  • Strategic Considerations for Electronic Discovery,  Philadelphia Area Society of Healthcare Risk Management, February 2014

  • The Internet and Social Media, 2013 Trends in Health Care and Health Law Seminar, Marshall Dennehey, November 7, 2013  

  • Electronic Discovery in Litigation and Issues Related to Electronic Medical Records, Cassatt, February 2013

  • Defending Nurses in Malpractice Claims, Souderton Mennonite Homes, 2011

Published Works


  • Rutgers, The State University of New Jersey School of Law-Newark, Newark, NJ (J.D., 2005)

  • Temple University, Philadelphia, PA (B.S., 1998)

Past Employment Positions

  • Sanofi-Aventis Pharmaceuticals, Inc., senior scientist/immunologist

  • Rhone-Poulenc-Rorer Pharmaceuticals, Inc., research chemist

Defense Digest Article March 1, 2019
Defense Digest, Vol. 25, No. 1, March 2019 Click to read article:  An Analysis of Commonly Used Statistics to Aid in the Development of Frye and Daubert Challenges     *Dave is a shareholder in our King of Prussia,..., Defense Digest, Vol. 25, No. 1, March 2019. Defense Digest is prepared by Marshall Dennehey Warner Coleman & Goggin to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal...
Defense Digest Article June 1, 2009
Pennsylvania -- Insurance Coverage & Bad Faith , In Jurinko v. Medical Protective et al., 2008 U.S. App. LEXIS 26263, Nos. 06-3519 & 06-3666 (Dec. 24, 2008), on appeal to the Third Circuit, there was an issue regarding whether an insurer acted in bad faith by having two separate insureds..., Defense Digest, Vol. 15, No. 2, June 2009
Jun 8, 2015
Obtained a unanimous jury verdict after a four-week trial in Bucks County, Pennsylvania. The plaintiffs' demand never moved from $9 million throughout the trial. The plaintiff family (mother, father and adult daughter) claimed that their house...
January 5, 2015
Marshall Dennehey Warner Coleman & Goggin announced today that 10 attorneys, half of them women, were elected shareholders of the firm at the annual shareholders' meeting held December 9 in Philadelphia. The new shareholders, categorized by office, are as follows. Philadelphia, PA:  Gregory W....


  • Rutgers, The State University of New Jersey School of Law-Newark (J.D., 2005)
  • Temple University (B.S., 1998)

Bar Admissions

  • New Jersey, 2005
  • Pennsylvania, 2005
  • U.S. District Court District of New Jersey, 2005
  • U.S. District Court Eastern District of Pennsylvania, 2008
  • U.S. Court of Appeals 3rd Circuit, 2008
  • U.S. Patent and Trademark Office, 2002

Associations & Memberships

  • American Association for the Advancement of Science
  • American Chemistry Association, Nominated Member
  • Pennsylvania State Bar Association

Year Joined Organization: 2008

Before you send this email please note:

You are attempting to send email, through a link on our website, to an attorney of Marshall Dennehey Warner Coleman & Goggin or an employee in our firm. Please note that your email may not be treated as confidential and does not create an attorney-client relationship. You should not rely upon the transmission of an email through this website if you are seeking to enter into such a relationship. Until such time as we have agreed to represent you, no information in your email will be treated as confidential. Please contact us directly by telephone at 1.800.220.3308 if it is your intent to seek legal counsel with our firm or convey confidential information.

If it is still your intent to send this email, knowing that it may not be treated as confidential, you may accept our terms of agreement by pressing "OK". If you choose not to accept these terms of agreement you may navigate away from this page by pressing "Cancel."